FDA Import Refusal AEK-2079757-6/10003/1 — Novartis Pharma AG
The FDA refused shipment AEK-2079757-6/10003/1 from Novartis Pharma AG (Switzerland) on Sep 30, 2026. The refused product falls under Drugs and Biologics — LETROZOLE (ANTI-NEOPLASTIC). Cited charge: 75 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Sep 30, 2026
- Country
- Switzerland
- Product Category
- Drugs and Biologics
- Product Code
- 62ICC85 LETROZOLE (ANTI-NEOPLASTIC)
- Charges
- 75